Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan; Center of Innovative Clinical Medicine, Okayama University Hospital, Okayama, Japan. Electronic address: [Email]
Human epidermal growth factor 2 (HER2) is a potential driver oncogene. Although HER2-targeted precision therapy has been tested in non-small cell lung cancer (NSCLC), the demographic characteristics of HER2-positive NSCLC have not been systematically defined.
